An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis

NCT02655679 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: VTP-38543
OTHER: Vehicle with Transcutol®P
OTHER: Vehicle without Transcutol®P

Sponsor

Vitae Pharmaceuticals, Inc.